Takahiro Masaki

2.3k total citations
59 papers, 1.7k citations indexed

About

Takahiro Masaki is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Takahiro Masaki has authored 59 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 29 papers in Epidemiology and 23 papers in Molecular Biology. Recurrent topics in Takahiro Masaki's work include Hepatitis C virus research (27 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (13 papers). Takahiro Masaki is often cited by papers focused on Hepatitis C virus research (27 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (13 papers). Takahiro Masaki collaborates with scholars based in Japan, United States and Italy. Takahiro Masaki's co-authors include Stanley M. Lemon, You Li, Daisuke Yamane, Takaji Wakita, David R. McGivern, Tetsuro Suzuki, Asako Murayama, Ryosuke Suzuki, Hideki Aizaki and Yoshiharu Matsuura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Takahiro Masaki

52 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takahiro Masaki Japan 22 943 775 641 303 152 59 1.7k
Thomas F. Baumert France 20 905 1.0× 803 1.0× 548 0.9× 391 1.3× 183 1.2× 35 1.8k
Tetsuro Shimakami Japan 25 906 1.0× 798 1.0× 999 1.6× 578 1.9× 182 1.2× 89 2.0k
Ranjit Ray United States 25 1.2k 1.2× 1.3k 1.6× 854 1.3× 408 1.3× 477 3.1× 45 2.4k
Paul Targett‐Adams United Kingdom 21 1.2k 1.2× 960 1.2× 678 1.1× 62 0.2× 148 1.0× 35 2.0k
Isao Nakano Japan 26 1.3k 1.4× 1.1k 1.5× 268 0.4× 78 0.3× 131 0.9× 106 1.9k
Rosalba Minisini Italy 27 944 1.0× 1.2k 1.5× 332 0.5× 112 0.4× 230 1.5× 104 2.1k
Hiromichi Dansako Japan 25 1.1k 1.2× 971 1.3× 636 1.0× 79 0.3× 463 3.0× 74 2.0k
Olivier Diaz France 18 405 0.4× 596 0.8× 335 0.5× 141 0.5× 200 1.3× 30 1.2k
Eiji Kakazu Japan 24 692 0.7× 927 1.2× 781 1.2× 371 1.2× 241 1.6× 75 2.0k
Vicky M.-H. Sung United States 12 1.1k 1.1× 784 1.0× 300 0.5× 60 0.2× 302 2.0× 14 1.6k

Countries citing papers authored by Takahiro Masaki

Since Specialization
Citations

This map shows the geographic impact of Takahiro Masaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Masaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Masaki more than expected).

Fields of papers citing papers by Takahiro Masaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Masaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Masaki. The network helps show where Takahiro Masaki may publish in the future.

Co-authorship network of co-authors of Takahiro Masaki

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Masaki. A scholar is included among the top collaborators of Takahiro Masaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Masaki. Takahiro Masaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tamura, Takashi, Mohamed Mahdi Alshahni, Toshiki Kobayashi, et al.. (2025). First Identification of Domestic Clade I <i>Candida auris</i> in Japanese Otitis Externa Patients Without Travel History. Medical Mycology Journal. 66(1). 21–25.
2.
Fujimi, Takahiko J., Yoshihiro Mezaki, Takahiro Masaki, et al.. (2020). Investigation of the effects of urea cycle amino acids on the expression of ALB and CEBPB in the human hepatocellular carcinoma cell line FLC-4. Human Cell. 33(3). 590–598. 3 indexed citations
3.
Yokoyama, Hiroshi, Takahiro Masaki, Ikuyo Inoue, et al.. (2019). Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease. Heliyon. 5(2). e01231–e01231. 11 indexed citations
5.
McGivern, David R., et al.. (2015). Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle. Journal of Virology. 89(10). 5362–5370. 32 indexed citations
6.
Li, You, Daisuke Yamane, Takahiro Masaki, & Stanley M. Lemon. (2015). The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA. Nature Reviews Microbiology. 13(9). 544–558. 29 indexed citations
7.
Masaki, Takahiro, You Li, Daisuke Yamane, et al.. (2015). miR-122 Stimulates Hepatitis C Virus RNA Synthesis by Altering the Balance of Viral RNAs Engaged in Replication versus Translation. Cell Host & Microbe. 17(2). 217–228. 104 indexed citations
8.
Selitsky, Sara R., Jeanette Baran‐Gale, Masao Honda, et al.. (2015). Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C. Scientific Reports. 5(1). 7675–7675. 115 indexed citations
9.
Yamane, Daisuke, David R. McGivern, Takahiro Masaki, & Stanley M. Lemon. (2013). Liver Injury and Disease Pathogenesis in Chronic Hepatitis C. Current topics in microbiology and immunology. 369. 263–288. 57 indexed citations
10.
Masaki, Takahiro, Asako Murayama, Tsubasa Munakata, et al.. (2011). Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2. Biochemical and Biophysical Research Communications. 410(3). 404–409. 6 indexed citations
11.
Suzuki, Tetsuro, Hiromichi Hara, Hideki Aizaki, Ryosuke Suzuki, & Takahiro Masaki. (2010). Advances in research on HCV replication and virion formation. Uirusu. 60(1). 87–92.
12.
Ueno, Makoto, Tetsu Niwa, Shinichi Ohkawa, et al.. (2009). The Usefulness of Perfusion-Weighted Magnetic Resonance Imaging in Advanced Pancreatic Cancer. Pancreas. 38(6). 644–648. 5 indexed citations
13.
Suzuki, Tetsuro, Takahiro Masaki, & Hideki Aizaki. (2008). Involvement of nonstructural protein 5A and lipids on production of hepatitis C virus particles. Uirusu. 58(2). 199–206. 2 indexed citations
14.
Nagatsuma, Keisuke, Yoshihiro Hayashi, Hiroshi Hano, et al.. (2008). Lecithin: retinol acyltransferase protein is distributed in both hepatic stellate cells and endothelial cells of normal rodent and human liver. Liver International. 29(1). 47–54. 30 indexed citations
15.
Rino, Yasushi, Kazuo Tarao, Shinichi Ohkawa, et al.. (2006). Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.. PubMed. 26(3B). 2221–6. 17 indexed citations
16.
Ueno, Makoto, Tetsu Niwa, S. Ohkawa, et al.. (2005). The prognostic value of perfusion-weighted magnetic resonance imaging in advanced pancreas carcinoma. Journal of Clinical Oncology. 23(16_suppl). 4109–4109. 1 indexed citations
18.
Tarao, Kazuo, Yasushi Rino, Shoji Takemiya, et al.. (2003). Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus‐associated liver cirrhosis. Cancer Science. 94(12). 1083–1090. 10 indexed citations
19.
Matsuura, Tomokazu, Masaya Saito, Masakiyo Hosokawa, et al.. (2003). Cyp3a4 Inducible Model For In Vitro Analysis of Human Drug Metabolism Using A Bioartificial Liver. Hepatology. 37(3). 665–673. 54 indexed citations
20.
Saeki, Hiroyuki, et al.. (2002). [Intraoperative radiotherapy (IORT) for unresectable stage IVb pancreatic cancer].. PubMed. 29(12). 2221–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026